AFJOG

Restore health and vibrancy Blossom with inner confidence S2 Fluomizin ® vaginal tablets. Each vaginal tablet contains 10 mg dequalinium chloride. Reg. No.: 55/18.6/0091. For full prescribing information, refer to the Professional Information approved by SAHPRA. February 2022. Adcock Ingram Limited. Co. Reg. No.: 1949/034385/06. Private Bag X69, Bryanston, 2021. Customer Care: 0860 ADCOCK/232625. www.adcock.com 20.01.20251000000936 January 2025. References: 1. Fluomizin ® approved professional information, 22 February 2022. 2. Raba G, Durkech A, Malík T, et al. Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial Vaginosis: A Randomized Clinical Trial. JAMA Netw Open . 2024;7(5):e248661. 3. Weissenbacher ER, Donders G, Unzeitig V, et al. A comparison of dequalinium chloride vaginal tablets (Fluomizin ® ) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety. Gynecol Obstet Invest. 2012;73:8-15. BV - bacterial vaginosis *vs clindamycin 2 % vaginal cream 3 # Fluomizin ® should only be used in pregnancy if clearly needed and can be used during lactation if clinically needed. 1 Fluomizin®: A novel 6-day vaginal tablet for Bacterial Vaginosis (BV) 1-3 - Quinoline derivative: broad-spectrum anti-infective and antiseptic for BV 1,2 - Rapid bactericidal action: relieves symptoms within 24 to 72 hours 1 - Clinical cure rate of 81,5 % within 7 days* 3 - May be used during pregnancy and lactation if clinically needed #1 - No observed mechanism of acquired resistance to-date 1 Empower women to thrive with vitality now! 19803